ClinicalTrials.gov record NCT07662603

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

Record copied from ClinicalTrials.gov: Oct 10, 2026AI summaries generated: Sep 17, 2026

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

StatusRecruitingThe study is currently enrolling participants. Only the study team can say whether a particular person can join.
Study typeInterventionalA study in which researchers assign participants to one or more interventions, such as a drug, procedure, device, behavioural programme or other approach, to measure their effects.
Age13 years old to 17 years old
SexAll
LocationEgypt
AI summaryWhat this study is about, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

This randomized study compares a 12-week inspiratory muscle training program with a waitlist group in adolescents with Behcet Disease after pulmonary endoarterectomy. Forty patients are planned, with 20 assigned to training and 20 to waitlist. Lung function, respiratory muscle strength, exercise capacity, fatigue, and quality-of-life measures are assessed after 12 weeks.

What it is studying. The study tests whether a 12-week program of inspiratory muscle training changes lung function (primary outcome: forced vital capacity) and other patient measures. Secondary measures include forced expiratory volume, the FEV1/FVC ratio, respiratory muscle pressures (inspiration and expiration), six-minute walk distance, fatigue severity, a parent-completed child health questionnaire (physical and mental summaries), and a Ruffier index for fitness.

What the researchers hope to learn. To measure the effects of inspiratory muscle training on lung function, respiratory muscle strength, exercise capacity, fatigue, and quality of life in adolescents with Behcet Disease after pulmonary endoarterectomy.

What this study is about

The study's own summary, as published on ClinicalTrials.gov. Underlined terms have a short explanation.

physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated

Interventions being studied

Being studied in this trial does not mean the treatment or procedure is approved or available for this condition.

Other
  • inspiratory muscle trianing

Eligibility

The criteria exactly as listed on ClinicalTrials.gov. Only the study team can say whether they apply to you.

Inclusion criteria

  • adlescent patients
  • complain Behcet disease
  • after pulmonary endoarterectomy

Exclusion criteria

  • chronci cardiac diseases
  • psychic disease
  • mental disease

Study description and what participation involves

The study's detailed description, as published on ClinicalTrials.gov.

Detailed description from the registry

Forty Behcet disease patients with pulmonary endoarterectomy will be assigned to group I or Group II. the patients will be adolescents, 20 patients in the group. Group I will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week) Group II will act waitlist group.

AI summaryWhat participation may involve, in plain languageShow ▾Hide ▴

AI-written from the registry record, not the study's own wording. May contain errors or omissions. Check the registry text on this page and the original record ↗ before acting on it.

If you join, you will be randomly assigned to one of two groups: a 12-week inspiratory muscle training program (one session per day, except the last two days of each week) or a 12-week waitlist group. The registry states the following outcomes will be measured after 12 weeks: lung function (forced vital capacity, forced expiratory volume in one second, and their ratio), breathing-muscle strength (maximal inspiratory and expiratory pressures), six-minute walk test, Ruffier index, the Fatigue Severity Scale, and the Child Health Questionnaire parent form. The registry does not list any invasive procedures.

How the study is structured. Participants are randomly assigned to one of two parallel groups and the study is single-masked. Group 1 receives inspiratory muscle training for 12 weeks (one session daily except the last two days of the week). Group 2 is a waitlist (no intervention) for 12 weeks. Outcomes listed in the registry are measured after the 12-week period.

Questions you could ask

These questions are suggestions for a conversation with the study team or your own clinician, not advice.

  • The registry lists this study under Behcet Disease. Does it apply to my diagnosis?
  • The listed sites are in Egypt. Is any of them reachable for me, and does the study help with travel?
  • Which of the eligibility criteria would need to be checked with tests before I could join?

More on familial Mediterranean fever

This trial is also listed on this site under Behçet's disease.

Clinical trials62 trials listed for familial Mediterranean feverEvery trial the registry lists for familial Mediterranean fever, with recruitment status, phase and sites, updated from ClinicalTrials.gov.See all trials →Research updatesWhat changed in familial Mediterranean fever researchLatest monthly update: September 2026. Includes: Colchicine form change. New research summarized each month in plain language, with links to every source paper.Read the latest update →

Important dates

Study start
May 6, 2026
Primary completion
Sep 6, 2026 (estimated)
Study completion
Sep 6, 2026 (estimated)
Target enrollment
40 participants (estimated)
Last updated on registry
Jun 23, 2026
Data verified
Oct 10, 2026

Sponsor and research team

The lead sponsor funds and oversees the trial. A pharmaceutical or biotech company sponsor typically means the study is testing that company's drug or device; a hospital, university, or government agency usually indicates investigator-initiated or publicly funded research.

Lead sponsor
Cairo University
Principal investigator
Ali Mohamed Ali ismail, lecturer of physical therapy for Cardiovascular, Respiratory disorder and Geriatrics, Faculty of Physical Therapy, Cairo University
Cairo University

Central study contact

If you're interested in participating, the central contact can answer general questions about the study — including eligibility requirements and how to find a recruiting site near you. Actual eligibility is determined by the site's medical team.

Participating sites (1)

Terms used on this page · explanations by MedicalUpdates.ai

Inclusion Criteria
The conditions a person must meet to be considered for the study, for example a confirmed diagnosis, an age range or a test result.
Exclusion Criteria
The conditions that rule a person out even if they meet the inclusion criteria, for example other illnesses, certain medicines or pregnancy.

The study record on this page is reproduced from ClinicalTrials.gov, a database of the U.S. National Library of Medicine, where it was submitted by the study sponsor. MedicalUpdates.ai does not own this content, is not affiliated with or endorsed by ClinicalTrials.gov, NIH, or the U.S. Government, and does not verify the record. Plain-language notes, the glossary and the questions above are added by this site; text in the boxes marked "AI summary" was written by an AI model and may contain errors. Registry records change over time. Check the original record for the current version and discuss eligibility or participation with a qualified healthcare professional.

← Back to clinical trials